Walz signs bill expanding protections for trainers of service dogs
U.S. sees 1,000 measles cases so far in 2025, and more headlines
U.S. sees 1,000 measles cases so far in 2025, and more headlines
U.S. sees 1,000 measles cases so far in 2025, and more headlines
Gov. Tim Walz Thursday morning signed a bill granting trainers of service dogs the same housing protections as people who rely on the animals to navigate daily life.
The measure ensures service dogs in training are exempt from homeowners association and apartment rules that do not allow dogs. Previously only active service dogs were afforded those accommodations.
Organizations like Can Do Canines in New Hope, which worked with lawmakers on the bill, say it can be challenging to find volunteers to raise the dogs. Among the barriers is housing and this proposal aims to make it easier for individuals to train them for service.
"In Minnesota, it is a core principle that everyone should be able to participate in all aspects of life. So this is incredible work, and this bill just makes the case of it," Walz told reporters. "These are not pets. These are not nice-to-have things. These are absolutely critical for the quality of life of the people who need them and the folks who train them know that it takes a lot of work and a lot of specialty work."
The bill received overwhelming bipartisan support in both chambers and the two DFL authors joined Walz when he signed it into law Thursday.
Sen. Bonnie Westlin, DFL-Plymouth, said the bill is "affirming our commitment to inclusivity and support for both the volunteers and future service dog users."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
an hour ago
- New York Times
Many Older People Embrace Vaccines. Research Is Proving Them Right.
Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out of pocket. Her doctor and several pharmacies turned her down because she was below the recommended age at the time, which was 60. So in 2016, she celebrated her 60th birthday at her local CVS. 'I was there when they opened,' Ms. Beckham recalled. After her Zostavax shot, she said, 'I felt really relieved.' She has since received the newer, more effective shingles vaccine, as well as the pneumonia shot, the R.S.V. vaccine, annual flu shots and all recommended Covid vaccinations. Some older people are really eager to be vaccinated. Robin Wolaner, 71, a retired publisher in Sausalito, Calif., has been known to badger friends who delay getting recommended shots, sending them relevant medical studies. 'I'm sort of hectoring,' she acknowledged. Deana Hendrickson, 66, who provides daily care for three young grandsons in Los Angeles, sought an additional M.M.R. shot, though she was vaccinated as a child, in case her immunity to measles was waning. For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought some welcome research. Studies have found important benefits from a newer vaccine and enhanced versions of older ones, and one vaccine may confer a major bonus that nobody had foreseen. Want all of The Times? Subscribe.
Yahoo
an hour ago
- Yahoo
Letters to Sports: Bill Plaschke is taking the fight to Parkinson's disease
Bill Plaschke, thank you for your very informative column about Parkinson's disease and your boxing exercise program. I was diagnosed with Parkinson's about five years ago and joined Rock Steady boxing in Burbank six months ago. We do Tai Chi, dancing, speech, the gym machines and boxing. We also work on stretching and floor exercises. My family has noticed a difference in my gait and my endurance. I hope that everyone with Parkinson's will take heed and find an exercise program specific to their needs. I never had a right jab before, but I have a good one now. Sandy Kaufman North Hollywood I'm often in the mood to punch him after reading one of Plaschke's columns, but after reading Sunday's column I wanted nothing more than to give him a hug. It reminds me that everyone is fighting a battle none of us can see. Be kind. Advertisement Bill Hokans Santa Ana Years of using Bill Plaschke's notoriously incorrect Super Bowl predictions for betting guidance has led me to believe that Bill owes me, as well as his many devoted readers, a significant debt. His brave and inspiring column revealing his ongoing battle with Parkinson's disease repays that debt, and then some. Rob Fleishman Placentia Don't mind admitting I was in tears reading about Bill Plaschke's advancing Parkinson's and the therapy that might slow the "motion-melting nightmare" down. A 78-year-old former rugby player with arthritis and a bum knee, I'm fortunate in not having to face the dreaded Parky (yet?). If it happens, I know where to go. Advertisement Rock on, Bill, and your truly inspiring gym mates. Kudos, also, to staff photographer Robert Gauthier … every picture, indeed, tells a story. John D.B. Grimshaw Lake Forest I too am living with Parkinson's disease. Plaschke's column helped to remind me that I am not alone and this dreaded disease indeed takes no prisoners no matter who you are. I wanted to thank Bill for his column bringing awareness, insight and hope to those of us diagnosed with Parkinson's. Bill's humanitarian columns with a tie-in to the world of sports showcase his best writing. Bill, your observations as a Parkinson's suffer truly hit the mark and deeply resonated with me. I wish you, and all of us afflicted with this condition, the willingness and determination to move forward and to use the power of sport and exercise to combat this devastating disease. Mike Feix Chino Hills Champion Bill Plaschke goes toe to toe against challenger 'Parky!' Plaschke delivers a vicious uppercut to his opponent. 'Down goes Parky, Down goes Parky!' Advertisement Rob Parra Rowland Heights Eye of the storm "Calm' is exactly right and what I admire most about Dodgers manager Dave Roberts. Not unlike his most illustrious predecessor, Walter Alston. Bob Wieting Simi Valley Back to the future Is the grass really greener if you can't see it? What poetic justice it would be if the Knicks had to end up rehiring Tom Thibodeau and have to give him more money and more authority? If it ain't broke don't fix it. Russell Morgan Carson Unheralded heroes It's been a minute since we've seen an outfielder with an arm like Andy Pages. I've taken to calling him the "Cuban Cannon." As for Hyeseong Kim, he has been a sparkplug for the offense. I am trying hard to figure out why he doesn't command more playing time. Advertisement John Tsutsui Hurricane, Utah Arms game Kiké "The Closer" Hernández. Who needs Shohei Ohtani, Blake Snell or Tyler Glasnow? Brent Montgomery Long Beach The Los Angeles Times welcomes expressions of all views. Letters should be brief and become the property of The Times. They may be edited and republished in any format. Each must include a valid mailing address and telephone number. Pseudonyms will not be used. Email: sports@ Get the best, most interesting and strangest stories of the day from the L.A. sports scene and beyond from our newsletter The Sports Report. This story originally appeared in Los Angeles Times.
Washington Post
an hour ago
- Washington Post
Celebrated, then disparaged: mRNA's promise is tarnished under Trump
The four letters were the toast of the scientific world, the engine powering vaccines developed in record time that saved millions of lives and helped tame the covid-19 pandemic: mRNA. But despite President Donald Trump's boasting in his first term that mRNA vaccines were a 'modern-day miracle,' his appointees are now throwing doubt on the technology with largely unfounded claims about its safety, canceling funding for future discoveries and handing key posts to prominent mRNA critics. The administration's abrupt turn against one of the biggest biotech breakthroughs in modern times has triggered confusion and worry among scientists and drug companies researching the use of mRNA to stem future pandemics, as well as to treat cancer, cystic fibrosis and other diseases.
